HIV molecular immunology database
Found 1 matching record:
Download this epitope record as JSON.
MAb ID | P1H6 | |
---|---|---|
HXB2 Location | gp160(143-148) DNA(6651..6668) |
gp160 Epitope Map |
Author Location | gp120( SF162) | |
Research Contact | Nina Derby or Leo Stamatatos, Seattle Biomedical Research Institute, Seattle, WA, USA, leo.stamatotos@sbri.org | |
Epitope |
SSNWKE
|
Epitope Alignment
|
Subtype | B | |
Ab Type | gp120 V1 | |
Neutralizing | ||
Species (Isotype) | mouse(IgG1κ) | |
Patient | ||
Immunogen | vaccine | |
Country | United States | |
Keywords | antibody binding site, neutralization |
Vaccine type | DNA prime with protein boost |
---|---|
Vaccine strain | B clade SF162 |
Vaccine component | gp140ΔV2 |
Showing 2 of 2 notes.
Showing 2 of 2 references.
Isolation Paper
Derby2007
Nina R. Derby, Sean Gray, Elizabeth Wayner, Dwayne Campogan, Giorgos Vlahogiannis, Zane Kraft, Susan W. Barnett, Indresh K. Srivastava, and Leonidas Stamatatos. Isolation and Characterization of Monoclonal Antibodies Elicited by Trimeric HIV-1 Env gp140 Protein Immunogens. Virology, 366(2):433-445, 30 Sep 2007. PubMed ID: 17560621.
Show all entries for this paper.
Ching2008 Lance K. Ching, Giorgos Vlachogiannis, Katherine A. Bosch, and Leonidas Stamatatos. The First Hypervariable Region of the gp120 Env Glycoprotein Defines the Neutralizing Susceptibility of Heterologous Human Immunodeficiency Virus Type 1 Isolates to Neutralizing Antibodies Elicited by the SF162gp140 Immunogen. J. Virol., 82(2):949-956, Jan 2008. PubMed ID: 18003732. Show all entries for this paper.